Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02759120 · ClinicalTrials.gov registry record · Phase 3
CleanUP IPF for the Pulmonary Trials Cooperative
A Phase 3 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 513
- Enrollment target
NCT02759120 is a Phase 3 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 513 participants.
The verdict
NCT02759120, a Phase 3 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 513 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of standard care, versus standard of care plus antimicrobial therapy (co-trimoxazole or doxycycline), on clinical outcomes in patients diagnosed with idiopathic pulmonary fibrosis (IPF).
Interventions
- DRUG Antimicrobial therapy: Co-trimoxazole or Doxycycline
- OTHER No Intervention: Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2017-03-22 |
| Est. Completion | 2020-03-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02759120
The ClinicalTrials.gov registry entry for NCT02759120 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 513 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Antimicrobial therapy: Co-trimoxazole or Doxycycline is the first listed.
NCT02759120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02759120 about?
NCT02759120 is a clinical study titled "CleanUP IPF for the Pulmonary Trials Cooperative". The purpose of this study is to compare the effect of standard care, versus standard of care plus antimicrobial therapy (co-trimoxazole or doxycycline), on clinical outcomes in patients diagnosed with idiopathic pulmonary fibrosis (IPF).
What is the current status of trial NCT02759120?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 513 participants. The study started on 2017-03-22. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT02759120?
The interventions under investigation include: Antimicrobial therapy: Co-trimoxazole or Doxycycline (DRUG), No Intervention: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT02759120?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.